From July 1, 2023 to September 30, 2023, the company has repurchased 68,012 shares, representing 0.26% for $0.03 million. With this, the company has completed the repurchase of 513,723 shares, representing 2.24% for $0.54 million under the buyback announced on January 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5126 USD | -2.34% | -18.18% | -98.11% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.11% | 10.57M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.